Euresearch has just published a success story about the IMI2 project RHAPSODY.

Diabetes is the pandemic of our time. Some 285 million people are diabetic and by 2030, it may affect 439 million, hitting children and young adults the hardest. “RHAPSODY” (Risk Assessment and Pro- gression of Diabetes) pools the data and expertise of 20 academic institutions, 4 pharma organisations, 1 biotech company and 1 management SME to discover how diabetes progresses. The goal is to develop precision therapy and prevention to stop the disease.

SCIPROM is glad to be part of RHAPSODY, supporting the consortium in management, communication and dissemination since its proposal stage.